Melissa Adams, APRN
Obstetrics & Gynecology · Fernandina Beach, FLNPI 1922502293
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,382 of the $1,581 with a category attached, or 87.4%. 20 manufacturers reported payments, led by Astellas Pharma US Inc at 26.1% of the total. Reporting peaked in 2022 at $447 and has fallen 62.1% since, to $169 in 2025.
Across 45 payments — averaging $35.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$412
- Edwards Lifesciences$202
- Stryker$169
- Mayne Pharma Commercial LLC$143
- Novo Nordisk$110
- Axonics, Inc.$66
- plus $478 from 14 others
What the payments were for
- Food & beverage$1,38287%
- Education$19913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 8 | $412 |
| Edwards Lifesciences | 1 | $202 |
| Stryker | 1 | $169 |
| Mayne Pharma Commercial LLC | 3 | $143 |
| Novo Nordisk | 1 | $110 |
| Axonics, Inc. | 3 | $66 |
| Urovant Sciences Inc | 4 | $64 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Amgen | 3 | $59 |
| Coloplast | 3 | $52 |
| Evofem Biosciences, Inc. | 2 | $37 |
| Exact Sciences | 2 | $35 |
| Therapeuticsmd, Inc. | 2 | $32 |
| Bayer | 2 | $31 |
| Exeltis, USA Inc. | 2 | $27 |
| AbbVie | 1 | $19 |
| Myovant Sciences Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Avion Pharmaceuticals | 1 | $13 |
| Scynexis, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$202
- MAKO$169
- Veozah$122
- NEXTSTELLIS$116
- Saxenda$110
How this compares
$1,581 in reported general payments places this provider in the 65th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 59 | $2,039 |
| ProgesteroneProgesterone, Micronized | 31 | $950 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $554 |
| Fluconazole | 26 | $379 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Fernandina Beach
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.